‘Skinny labels’ on generics can save patients money, research shows, but recent court decisions cloud future

‘Skinny labels’ on generics can save patients money, research shows, but recent court decisions cloud future

Source: 
Endpoints
snippet: 

New research shows how generic drug companies can successfully market a limited number of approved indications for a brand name drug, prior to coming to market for all of the indications. But several recent court decisions have created a layer of uncertainty around these so-called “skinny” labels.